Dr. Mahmoud Halima

• PhD in Immuno-pharmacology from Leiden University, Netherlands.

• Project Manager at Leiden University and Hospital, and the Chinese-European Institute for Drug Discovery and Development.

• CEO of Ultra Group in Turkey for International Industries.

• CEO of Ultra Biomed in the Netherlands.

• Consultant at Neta Pharm for Pharmaceutical Industries.

• Former Head of the Drug Laboratory at the Center for Scientific Studies and Research.

• Bachelor's degree in Veterinary Medicine and Surgery (2003).

• Master's degree in Biomedical Medicine (2018).

• PhD in Immunology from Leiden University (2022).

Key Achievements:

• Five patents: three national and two international in the field of drug development.
• Development of an antidote for snake venom.
• Development of an antidote for scorpion venom.
• Development of an antidote for nerve gases and chemical weapons.
• Development of treatments for complex autoimmune diseases.
• Development of a treatment for eye cancer.

Years of Experience: 22 years.